AKBMo — Aker Biomarine ASA Balance Sheet
0.000.00%
- NOK4.71bn
- NOK6.09bn
- $199.00m
- 30
- 48
- 44
- 31
Annual balance sheet for Aker Biomarine ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 9.09 | 9.15 | 22.3 | 25.3 | 14.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 64.1 | 60.4 | 82.7 | 66.2 | 50 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 223 | 240 | 299 | 283 | 202 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 280 | 339 | 343 | 351 | 51.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 700 | 757 | 825 | 827 | 387 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 70.9 | 77.3 | 105 | 113 | 53.2 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 327 | 387 | 446 | 461 | 214 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 373 | 370 | 379 | 367 | 174 |
Total Liabilities & Shareholders' Equity | 700 | 757 | 825 | 827 | 387 |
Total Common Shares Outstanding |